Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc - Seite 2

SofPulse Inc. Drives Revenue Growth with Expanded Distribution

SofPulse Pulsed Electro Magnetic Field (PEMF) medical technology, utilizing its FDA-clearance for the reduction of pain and edema post-operatively, helps to position the Company as a leader in the development of innovative medical devices.

To drive revenue and future expansion, SofPulse, Inc. aims to build on current marketing distribution initiatives for long-term growth and stability in the following areas:

• Development of Veterans Association (VA) and Department of Defense (DoD) post-operative pain management market for SofPulse.
• Expand distribution throughout Taiwan, building on Taiwan FDA clearance.
• Increase expansion efforts into other Asian markets such as Singapore, South Korea, Thailand, and Hong Kong.
• Grow International distribution of SofPulse in Mexico, Central and South America.
• Re-initiate efforts to penetrate European markets with SofPulse devices.
• Expand and develop SofPulse devices and other new PEMF medical devices for commercialization to all US hospital, surgical and rehabilitation facilities.

Endonovo Market Outlook is Extremely Positive

The Endonovo management team is excited about the completion of the APA and looks forward to the continued growth and success of Endonovo Therapeutics, Inc. through the following areas of business:

• Exclusive rights to develop non-medical human PEMF IP and wellness markets.
• Development of new non-medical wellness products for the expanding U.S. PEMF therapy device wellness market.
• Utilization of groundbreaking multi-coil IP technology for over-the-counter PEMF product development in wellness and human markets.
• Maintenance of rights to develop comprehensive telehealth division and platform (SofPulse, Inc. has signed an exclusive agreement to be a customer with a five-year contract).
• Continued focus on mergers and acquisitions division to enhance product offerings for new technology and IP.
  

Endonovo, as business continues to expand, offers additional value to shareholders with the development of the non-medical Wellness market and other opportunities planned by the Company to sustain its long-term growth.

SofPulse PEMF Benefits and Technology Featured in The Press

SofPulse's effective non-pharmacological PEMF pain and inflammation management solutions were highlighted in a recent article by Wallstreetpr.com, titled "Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)." The article can be found on MarketScreener, Barchart.com, abnewswire, Benzinga, Muck Rack, The Globe and Mail, and other news outlets.